IDO1 and neoplasm: Targeting immunosuppressive IDO expressed by tumor cells and dendritic cells has shown great T cell‐based immune enhancement ability when combined with other treatment modalities, such as radiotherapy, chemotherapy, and immune checkpoint blockade.[138] Therefore, Zhang et al.